News & insights

Press releases
Article
September 10, 2026
Prime Therapeutics names Manmohan Mahajan chief financial officer

Mahajan brings more than 20 years of global finance and leadership experience across healthcare, pharmacy and financial services organizations

Article
March 10, 2026
Prime Therapeutics delivers more than $100 million in savings by improving care coordination and reducing treatment delays for cancer and cystic fibrosis patients

Prime’s IntegratedRx® model brings pharmacists and providers together to improve care and reduce costs

Article
November 13, 2025
Prime Therapeutics appoints public affairs veteran Katie Payne as chief external affairs officer

Payne to integrate communications, government affairs and policy efforts at leading purpose-driven, transparent PBM

Article
October 30, 2025
Prime Therapeutics supports FDA’s updated biosimilar recommendations

New approach aligns with long-standing biosimilar strategy

Article
October 27, 2025
Prime Therapeutics to present latest managed care pharmacy insights at AMCP Nexus 2025

Research on GLP-1 drugs, specialty therapies and more helps improve affordability in health care

Article
October 01, 2025
Prime Therapeutics Scales Judi® Platform Implementations with Support from PwC

Accelerated platform deployment meets rising demand for pharmacy innovation 

Article
September 04, 2025
What's driving medical benefit spend? Prime Therapeutics trend report shares new clues
Article
June 25, 2025
Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years

Findings also show improved persistence with high-potency,  
obesity-approved GLP-1 products

Article, Awards
March 31, 2025
Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025

Prime to present seven studies and receive the 2024 JMCP Award for Excellence

Article
October 24, 2024
Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity

Real-world study of GLP-1 patients continues to deliver leading insights

Article
October 15, 2024
Medical benefit drug trend: Prime Therapeutics Medical Pharmacy Trend Report™ goes behind the numbers

Prime’s signature report — with its deep insights and forecasting — recognized in health care industry as credible source to inform payer strategies

Article
October 10, 2024
Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024

Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.

Showing 1 to 12 of 44